Skip to main content

Albert Selva O'Callaghan

I've been a doctor for over 30 years now and I work at the Vall d'Hebron University Hospital.

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca
Internal Medicine
General Hospital
Albert Selva O'Callaghan

Albert Selva O'Callaghan

Albert Selva O'Callaghan

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca
Internal Medicine
General Hospital

I've been a doctor for over 30 years now and I work at the Vall d'Hebron University Hospital.

Was born in Barcelona on May 1st, 1959. He obtained his medical degree at the University Autonomous of Barcelona in 1982, and so he did also the Doctoral Thesis at the same University in 1992. Since 2010 he is Associated Professor of Medicine, since june 2021 Full Professor. He attended to the internal resident program (MIR) at the Internal Medicine Department at Vall d’Hebron General Hospital in Barcelona from 1986 to 1990, and currently is working as a Senior Consultant and as Head at the Systemic Autoimmune Diseases Unit at the same hospital. He has been focused to the study of idiopathic inflammatory myopathy for more than 25 years and has published several relevant articles and book chapters on the field. Taking care of the patients, teaching at the University and doing research are the three main activities in regard to myositis patients he is committed to.

Research lines

Lung involvement in inflammatory myopathies.

With this study we want to study the natural history of this syndrome mediated by anti-synthetase antibodies, the characterization of new antibodies that may be used as markers for lung involvement, as well as we aim at understanding better the etiopathogenicity and the treatment of this organic illness in patients with myositis.

IP: Albert Selva O'Callaghan

Projects

Autoinmunitat i Malaltia Trombotica

IP: Albert Selva O'Callaghan
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2017SGR01129
Duration: 01/01/2017 - 31/12/2020

Identificación de nuevos antígenos en pacientes con miopatía inflamatoria

IP: Albert Selva O'Callaghan
Collaborators: Ernesto Trallero Araguas
Funding agency: Instituto de Salud Carlos III
Funding: 121000
Reference: PI15/02100
Duration: 01/01/2016 - 30/11/2020

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Proteinas TIF1 y dermatomiositis paraneoplásicas

IP: Ernesto Trallero Araguas
Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega, Albert Selva O'Callaghan, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 121000
Reference: PI12/01320
Duration: 01/01/2013 - 31/12/2016

Related news

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Related professionals

Stefania Orlando

Stefania Orlando

Main researcher
Molecular Imaging and Therapy
Read more
Montserrat Romero Reinaldos

Montserrat Romero Reinaldos

Research technician
Clinical Neuroimmunology
Read more
Charlene Leraitre

Charlene Leraitre

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Sergio Lopez Gandul

Sergio Lopez Gandul

Research assistant
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.